Presepsin Test

---

Disclaimer: This information is provided for clinical reference and educational purposes only and is not a substitute for professional medical judgment, diagnosis, or treatment. Clinical decisions must always be tailored to the individual patient based on the treating physician's assessment.

Overview

• Definition: Presepsin (sCD14-ST, soluble cluster of differentiation 14 subtype) is a biomarker used primarily for the diagnosis and prognosis of sepsis. It is the truncated, soluble form of CD14, a receptor expressed mainly on monocytes and macrophages, involved in the recognition of pathogen-associated molecular patterns (PAMPs), particularly bacterial lipopolysaccharide (LPS).
• Epidemiology: Sepsis affects millions globally and is a leading cause of death in critically ill patients. Rapid diagnosis is crucial, and presepsin is evaluated as a potential early, reliable marker of the systemic inflammatory response to infection, often outperforming traditional markers like C-reactive protein (CRP) and achieving comparable or superior performance to procalcitonin (PCT) in some settings.
• Classification: Presepsin itself is a biomarker, not a condition. Its classification relates to its utility:
  • Diagnostic Biomarker: Used to confirm or exclude sepsis, particularly bacterial sepsis.
  • Prognostic Marker: Used to predict 28-day mortality and severity scores (e.g., SOFA score).
  • Monitoring Tool: Used to track response to antibiotic therapy and resolution of infection.

Pathophysiology

• Mechanism:
  1. Infection Recognition: When bacterial infection occurs, LPS (endotoxin) binds to the LPS-binding protein (LBP) in the plasma, and this complex is presented to the CD14 receptor on macrophages and monocytes.
  2. Immune Activation: Binding of LPS/LBP to CD14 initiates intracellular signaling via Toll-like receptor 4 (TLR4), leading to the massive release of pro-inflammatory cytokines (the "cytokine storm").
  3. Presepsin Generation: Activation of immune cells results in the cleavage of the membrane-bound CD14 receptor by proteases (likely matrix metalloproteinase or cathepsin G). The resulting 13-kDa N-terminal fragment, known as presepsin, is released into the circulation.
  4. Kinetics: Presepsin concentrations rise rapidly (within 2-4 hours) after the onset of systemic infection, often earlier than CRP and sometimes earlier than PCT, making it valuable for early detection. It clears primarily via the kidneys.
• Risk Factors (for High Presepsin Levels):
  • Severe bacterial infection (Sepsis, Septic shock)
  • Immunosuppression
  • Chronic kidney disease (CKD) – levels are elevated due to impaired clearance, requiring adjusted cut-offs.
  • Post-surgical state (transient elevation)
• Protective Factors:
  • Prompt and effective source control and antimicrobial therapy.
  • Healthy immune status.

Clinical Presentation

Presepsin is a laboratory marker and does not have primary clinical signs, but elevated levels suggest severe underlying systemic inflammation, typically associated with the clinical syndrome of sepsis.

Signs and Symptoms (of Sepsis)

• Cardinal Features: Fever or hypothermia, tachycardia (>90 bpm), tachypnea (>22 breaths/min or $\text{PaCO}_2 < 32 \text{ mmHg}$), altered mental status.
• Early Signs (SIRS/Sepsis): Chills, malaise, signs of localized infection.
• Advanced Signs (Septic Shock): Hypotension refractory to fluid challenge, need for vasopressors, oliguria, mottled skin, capillary refill time > 3 seconds, disseminated intravascular coagulation (DIC).
• Atypical Presentations: In the elderly or immunocompromised, the presentation may be subtle, characterized only by confusion or mild hypothermia.

Physical Examination

Findings are those of the underlying source of infection and the systemic effects of shock.

• Inspection: Signs of infection (cellulitis, wound discharge), altered mental status, poor peripheral perfusion (mottling, prolonged capillary refill).
• Palpation: Tachycardia, weak peripheral pulses, abdominal tenderness.

Diagnostic Approach

The Presepsin test is used to support the clinical diagnosis of sepsis (Sepsis-3 criteria).

History Taking

• Key Questions: Onset and progression of symptoms (fever, chills, dyspnea), presence of potential infection sources (recent surgery, indwelling catheters, cough, dysuria), baseline functional status.
• Red Flags: Failure to recognize infection site, signs of organ dysfunction (new requirement for mechanical ventilation, acute kidney injury, lactic acidosis).

Laboratory Tests (The Role of Presepsin)

Presepsin Cut-off Values

Note: Cut-off values vary by assay manufacturer and clinical setting. The following are consensus values derived from meta-analyses.

Clinical Condition	Suggested Presepsin Cut-off Value	Sensitivity/Specificity	Clinical Interpretation
Sepsis (Diagnosis)	> 600 - 800 pg/mL	High sensitivity (around 80-90%)	Supports diagnosis of sepsis (comparable to PCT).
Severe Sepsis/Septic Shock	> 1000 - 1500 pg/mL	Good negative predictive value	Suggests high severity and potential need for aggressive intervention.
Normal Range (Healthy)	< 200 pg/mL	Baseline value	Excludes systemic bacteremia/sepsis

• First-Line (Routine Sepsis Workup):
  • Blood Cultures: Must be drawn before administering antibiotics (at least two sets, aerobic and anaerobic).
  • Lactate: Serum lactate (> 2 mmol/L is critical; > 4 mmol/L indicates severe hypoperfusion).
  • CBC with Differential: Leukocytosis or leukopenia, thrombocytopenia.
  • Basic Metabolic Panel: Assess for acute kidney injury, electrolyte abnormalities.
• Confirmatory (Specific Sepsis Markers):
  • Presepsin: Used particularly in the emergency department setting for early triage and decision-making regarding initiation of antibiotics. High levels support bacterial sepsis.
  • Procalcitonin (PCT): Standard biomarker. Levels > 0.5 ng/mL suggest bacterial infection; > 2.0 ng/mL strongly suggests severe sepsis/shock.
  • C-Reactive Protein (CRP): General inflammatory marker, useful for monitoring, but less specific and slower to rise than Presepsin/PCT.
• Monitoring:
  • Serial Presepsin Measurements: A decline in presepsin levels within 24-72 hours generally correlates with effective treatment and clinical improvement. Failure of levels to decline, or a persistent elevation, is associated with poor prognosis and treatment failure.

Imaging

Imaging is directed at identifying the source of infection, not diagnosing presepsin itself.

• Recommended: Chest X-ray (pneumonia), Abdominal/Pelvic CT or Ultrasound (source control, abscess), Plain films of extremities (osteomyelitis).

Management

Management of elevated presepsin levels is the management of the underlying source of infection and systemic inflammatory response (Sepsis/Septic Shock).

Acute Management (Sepsis Bundle: Hour-1 Bundle)

Presepsin informs this process by supporting the rapid decision to initiate antibiotics.

• Immediate: Measure lactate level (re-measure if initial level > 2 mmol/L).
• Stabilization (Resuscitation):
  1. Obtain blood cultures prior to antibiotic administration.
  2. Administer broad-spectrum antibiotics (within 1 hour of recognition of sepsis).
  3. Rapid administration of 30 mL/kg crystalloid for hypotension or lactate $\ge 4 \text{ mmol/L}$.
  4. Apply vasopressors (e.g., norepinephrine) if hypotensive during or after fluid resuscitation to maintain MAP $\ge 65 \text{ mmHg}$.
• Emergency: Source control (drainage of abscess, removal of infected hardware) must be instituted urgently, often within the first 6-12 hours after diagnosis.

Chronic Management

This phase focuses on rehabilitation and recovery from critical illness, as presepsin is an acute phase reactant.

• Non-pharmacological: ICU recovery teams, early mobilization, nutritional support.
• Monitoring: Follow-up to ensure resolution of the inflammatory state (normalization of CRP, PCT, and Presepsin), monitoring for long-term complications (post-sepsis syndrome).

Treatment Algorithms

Presepsin is primarily a diagnostic gate:

1. Initial Suspect Sepsis: Clinical suspicion + qSOFA criteria fulfillment.
2. Biomarker Testing: Draw blood cultures, Lactate, PCT, and Presepsin.
3. High Presepsin/PCT/Lactate: Treat as Sepsis. Initiate Hour-1 bundle (broad-spectrum IV antibiotics and fluid resuscitation).
4. Low Presepsin/PCT (e.g., < 200 pg/mL Presepsin): Less likely to be bacterial sepsis. Consider non-infectious causes (e.g., pancreatitis, trauma, cardiogenic shock) or early viral infection. May allow for antibiotic de-escalation or avoidance, especially if culture results are negative.

Complications (of Untreated or Severe Sepsis)

• Common: Acute Kidney Injury (AKI), delirium, respiratory failure requiring mechanical ventilation.
• Serious: Septic shock, Multiple Organ Dysfunction Syndrome (MODS), Disseminated Intravascular Coagulation (DIC), death.
• Long-term: Post-sepsis syndrome (cognitive impairment, muscle weakness, depression, chronic pain).

Prognosis

Presepsin is a potent prognostic indicator.

• Factors:
  • Initial Presepsin Level: Higher baseline levels (e.g., > 1500 pg/mL) are significantly associated with higher 28-day mortality.
  • Kinetic Change: Failure of presepsin levels to decrease by $\ge 40\%$ from the baseline within 48-72 hours is a strong predictor of poor outcome and mortality.
  • Baseline Comorbidities: Immunosuppression, CKD, advanced age.
• Survival: Studies consistently show that presepsin levels correlate with SOFA and APACHE II scores. Patients presenting with septic shock and presepsin levels approaching or exceeding 2000 pg/mL have significantly higher mortality rates (often > 50%).

Prevention

Presepsin is not directly preventable, but the condition it indicates (sepsis) is.

• Primary: Infection control measures (hand hygiene, proper catheter care), timely vaccination (influenza, pneumococcus).
• Secondary: Rapid recognition of infection, early measurement of biomarkers (including presepsin in high-risk patients), and adherence to the Sepsis Hour-1 bundle.
• Tertiary: Aggressive critical care management to prevent MODS, rehabilitation to mitigate post-sepsis syndrome.

Special Populations

• Pediatric: Presepsin shows promising diagnostic accuracy for neonatal and pediatric sepsis, often surpassing CRP and rivaling PCT. Specific age-adjusted cut-offs may be necessary, especially in neonates who have physiologically elevated levels.
• Geriatric: Sepsis presentation is often atypical. Presepsin is valuable because its rapid rise helps distinguish infection from non-infectious causes of delirium and inflammation common in the elderly.
• Pregnancy: Limited data; caution is advised as inflammatory markers can be altered during normal pregnancy. Standard sepsis guidelines apply.
• Comorbidities (Chronic Kidney Disease): Elevated baseline presepsin levels due to reduced renal clearance. Note: Presepsin levels must be interpreted cautiously in patients with severe CKD (GFR < 30-60 mL/min/1.73 $\text{m}^2$). An absolute value may be less reliable than the trend (kinetics) and the relative rise from baseline. A cut-off of up to 1000 pg/mL may be considered the "normal" high for severe CKD patients without sepsis.

Clinical Pearls

• Diagnostic: Presepsin and PCT are complementary. Presepsin rises very quickly (within 2 hours), making it ideal for the Emergency Department triage to rule out early sepsis. PCT often peaks later (6-12 hours). If both are highly elevated, the diagnosis of bacterial sepsis is strongly supported.
• Treatment: Use presepsin clearance kinetics as a guide for de-escalation. A reduction of $\ge 40\%$ in 48-72 hours suggests appropriate antimicrobial selection and source control; if the value is unchanged or rising, reassess the source, coverage, and resistance.
• Pitfalls: Significant elevations in presepsin occur in severe CKD and patients undergoing hemodialysis, limiting its absolute diagnostic specificity in this population. Similarly, transient elevations may occur immediately post-trauma or major surgery, necessitating serial measurements to establish a new septic process.

Recent Updates

• Guidelines: Consensus guidelines (e.g., Surviving Sepsis Campaign) acknowledge the utility of multiple biomarkers, yet currently emphasize PCT over Presepsin due to broader availability and established literature. However, newer guidelines are recognizing Presepsin's strength in rapid triage and prognostic stratification.
• Evidence: Recent meta-analyses (2020-2023) confirm that Presepsin has equivalent or slightly superior diagnostic accuracy for sepsis compared to PCT, particularly for early diagnosis (high AUC values consistently reported, often 0.85-0.90 for sepsis identification).
• Controversies: Debates persist regarding standardized cut-off values across different commercial assays and different patient populations (e.g., CKD, pediatrics). The cost-effectiveness compared to PCT remains a practical consideration, particularly in resource-limited settings.

Key References

• Guidelines:
  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA (2016). (Defines the clinical syndrome to which presepsin applies).
  • Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock. Crit Care Med (Latest edition).
• Studies:
  • Landmark studies validating Presepsin accuracy (e.g., Caironi et al., Yaegashi et al.) demonstrating strong correlation between Presepsin levels and SOFA score changes.
  • Meta-analyses comparing the diagnostic accuracy of Presepsin and Procalcitonin for sepsis and septic shock (e.g., relevant publications in Critical Care or Infection journals, 2018-present).
• Reviews:
  • Comprehensive reviews on novel biomarkers for sepsis diagnosis, detailing the pathophysiology and clinical application of Presepsin (sCD14-ST).